 <h1>Fulvestrant Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to fulvestrant: intramuscular solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, fulvestrant may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking fulvestrant:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blood in the urine or stools</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain or tightness</li>
<li>chills</li>
<li>cloudy urine</li>
<li>cough</li>
<li>difficulty breathing</li>
<li>fainting</li>
<li>fever</li>
<li>hoarseness</li>
<li>irregular heartbeat, recurrent</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>rapid weight gain</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>tender, swollen glands in the neck</li>
<li>tingling of the hands or feet</li>
<li>trouble with swallowing</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>confusion</li>
<li>dizziness or lightheadedness</li>
<li>fast heartbeat</li>
<li>mood or mental changes</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>numbness and tingling around the mouth, fingertips, or feet</li>
<li>pain in the chest, groin, or legs, especially the calves</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>seizures</li>
<li>severe, sudden headache</li>
<li>slurred speech</li>
<li>stomach cramps</li>
<li>sudden loss of coordination</li>
<li>sudden, severe weakness or numbness in the arm or leg</li>
<li>tremor</li>
<li>vision changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dark urine</li>
<li>flushing or redness of the skin</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>hives or welts, itching, skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>light-colored stools</li>
<li>nausea</li>
<li>stomach pain, continuing</li>
<li>upper right abdominal pain</li>
<li>vaginal bleeding</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of fulvestrant may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>bladder pain</li>
<li>body aches or pain</li>
<li>bone pain</li>
<li>change in or loss of taste</li>
<li>constipation</li>
<li>decreased appetite</li>
<li>depression</li>
<li>diarrhea</li>
<li>difficulty having a bowel movement</li>
<li>difficulty with moving</li>
<li>dry skin</li>
<li>dryness or soreness of the throat</li>
<li>feeling of warmth or heat</li>
<li>feeling sad or empty</li>
<li>frequent urge to urinate</li>
<li>general feeling of discomfort or illness</li>
<li>hair loss or thinning of hair</li>
<li>irritability</li>
<li>joint pain</li>
<li>lack or loss of appetite</li>
<li>lack or loss of strength</li>
<li>loss of interest or pleasure</li>
<li>muscle aches and pains</li>
<li>muscle stiffness</li>
<li>pain at the injection site</li>
<li>pain in the arms or legs</li>
<li>pelvic pain</li>
<li>shivering</li>
<li>stomach pain</li>
<li>sudden sweating</li>
<li>trouble concentrating</li>
<li>voice changes</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Dry eye</li>
<li>dry mouth</li>
<li>increased tearing</li>
<li>nervousness</li>
<li>swelling or redness in the joints</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Feeling of constant movement of self or surroundings</li>
<li>sensation of spinning</li>
</ul><p>
<!-- end intramuscular solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fulvestrant: intramuscular solution</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 34%), stomatitis (up to 28%), diarrhea (up to 24%), vomiting (up to 19%), abdominal pain (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Constipation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (up to 83%), leukopenia (up to 53%), anemia (up to 30%), thrombocytopenia (up to 23%)</p>
<p><b>Common</b> (1% to 10%): Reduced platelet count</p>
<p><b>Uncommon</b> (0.1% to 1%): Leukorrhea, febrile neutropenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Vasodilation(up to 18%), hot flushes</p>
<p><b>Common</b> (1% to 10%): Venous thromboembolism<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Bone pain (up to 16%), muscle pain, joint pain</p>
<p><b>Common</b> (1% to 10%): Back pain, pain in extremity<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Sciatica, peripheral neuropathy, dysgeusia, dizziness, paresthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Neuralgia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis (up to 16%), dyspnea (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Epistaxis, cough, chest pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Pelvic Pain (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Urinary tract infection, vaginal hemorrhage</p>
<p><b>Uncommon</b> (0.1% to 1%): Vaginal moniliasis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (up to 18%), rash (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Dry skin, sweating, pruritus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very common</b> (10% or more): Hypersensitivity reactions</p>
<p><b>Uncommon</b> (0.1% to 1%): Anaphylaxis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevated hepatic enzymes (ALT, AST, ALP)</p>
<p><b>Common</b> (1% to 10%): Elevated bilirubin</p>
<p><b>Uncommon</b> (0.1% to 1%): Hepatic failure, hepatitis, elevated gamma-GT<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infections (up to 47%)</p>
<p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (up to 12%), injection site reaction</p>
<p><b>Common</b> (1% to 10%):</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site hemorrhage, injection site hematoma<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Increased lacrimation, blurred vision, dry eye<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 16%)</p>
<p><b>Common</b> (1% to 10%): Peripheral edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, depression, anxiety<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 41%), pain (up to 19%), pyrexia (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Asthenia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Faslodex (fulvestrant)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How long does it take for Faslodex to start working?</li>
<li>How long can you take Faslodex?</li>
<li>Is Faslodex a form of chemotherapy?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about fulvestrant</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>24 Reviews</li>
<li>Drug class: estrogen receptor antagonists</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Fulvestrant Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Faslodex</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer</li>
<li>Breast Cancer, Metastatic</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fulvestrant: intramuscular solution</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 34%), stomatitis (up to 28%), diarrhea (up to 24%), vomiting (up to 19%), abdominal pain (up to 12%)</p><p><b>Common</b> (1% to 10%): Constipation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (up to 83%), leukopenia (up to 53%), anemia (up to 30%), thrombocytopenia (up to 23%)</p><p><b>Common</b> (1% to 10%): Reduced platelet count</p><p><b>Uncommon</b> (0.1% to 1%): Leukorrhea, febrile neutropenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Vasodilation(up to 18%), hot flushes</p><p><b>Common</b> (1% to 10%): Venous thromboembolism<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Bone pain (up to 16%), muscle pain, joint pain</p><p><b>Common</b> (1% to 10%): Back pain, pain in extremity<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 15%)</p><p><b>Common</b> (1% to 10%): Sciatica, peripheral neuropathy, dysgeusia, dizziness, paresthesia</p><p><b>Uncommon</b> (0.1% to 1%): Neuralgia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis (up to 16%), dyspnea (up to 15%)</p><p><b>Common</b> (1% to 10%): Epistaxis, cough, chest pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Pelvic Pain (up to 10%)</p><p><b>Common</b> (1% to 10%): Urinary tract infection, vaginal hemorrhage</p><p><b>Uncommon</b> (0.1% to 1%): Vaginal moniliasis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (up to 18%), rash (up to 17%)</p><p><b>Common</b> (1% to 10%): Dry skin, sweating, pruritus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very common</b> (10% or more): Hypersensitivity reactions</p><p><b>Uncommon</b> (0.1% to 1%): Anaphylaxis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevated hepatic enzymes (ALT, AST, ALP)</p><p><b>Common</b> (1% to 10%): Elevated bilirubin</p><p><b>Uncommon</b> (0.1% to 1%): Hepatic failure, hepatitis, elevated gamma-GT<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infections (up to 47%)</p><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (up to 12%), injection site reaction</p><p><b>Common</b> (1% to 10%):</p><p><b>Uncommon</b> (0.1% to 1%): Injection site hemorrhage, injection site hematoma<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Increased lacrimation, blurred vision, dry eye<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 16%)</p><p><b>Common</b> (1% to 10%): Peripheral edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, depression, anxiety<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 41%), pain (up to 19%), pyrexia (up to 13%)</p><p><b>Common</b> (1% to 10%): Asthenia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Faslodex (fulvestrant)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How long does it take for Faslodex to start working?</li>
<li>How long can you take Faslodex?</li>
<li>Is Faslodex a form of chemotherapy?</li>
</ul><h2>More about fulvestrant</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>24 Reviews</li>
<li>Drug class: estrogen receptor antagonists</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Fulvestrant Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer</li>
<li>Breast Cancer, Metastatic</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>